- Home
- AMIX vs CELZ Comparison
AMIX vs CELZ Comparison
Compare AMIX & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMIX
- CELZ
- Stock Information
- Founded
- AMIX 2014
- CELZ 1998
- Country
- AMIX United States
- CELZ United States
- Employees
- AMIX N/A
- CELZ N/A
- Industry
- AMIX
- CELZ Biotechnology: Pharmaceutical Preparations
- Sector
- AMIX
- CELZ Health Care
- Exchange
- AMIX NYSE
- CELZ Nasdaq
- Market Cap
- AMIX 4.9M
- CELZ 5.5M
- IPO Year
- AMIX N/A
- CELZ N/A
- Fundamental
- Price
- AMIX $1.95
- CELZ $2.02
- Analyst Decision
- AMIX Strong Buy
- CELZ
- Analyst Count
- AMIX 1
- CELZ 0
- Target Price
- AMIX $5.00
- CELZ N/A
- AVG Volume (30 Days)
- AMIX 347.1K
- CELZ 34.9K
- Earning Date
- AMIX 05-30-2025
- CELZ 05-09-2025
- Dividend Yield
- AMIX N/A
- CELZ N/A
- EPS Growth
- AMIX N/A
- CELZ N/A
- EPS
- AMIX N/A
- CELZ N/A
- Revenue
- AMIX N/A
- CELZ $14,000.00
- Revenue This Year
- AMIX N/A
- CELZ N/A
- Revenue Next Year
- AMIX N/A
- CELZ N/A
- P/E Ratio
- AMIX N/A
- CELZ N/A
- Revenue Growth
- AMIX N/A
- CELZ 55.56
- 52 Week Low
- AMIX $1.52
- CELZ $1.69
- 52 Week High
- AMIX $75.80
- CELZ $6.90
- Technical
- Relative Strength Index (RSI)
- AMIX 50.80
- CELZ 44.81
- Support Level
- AMIX $1.67
- CELZ $1.94
- Resistance Level
- AMIX $1.96
- CELZ $2.20
- Average True Range (ATR)
- AMIX 0.21
- CELZ 0.14
- MACD
- AMIX -0.01
- CELZ 0.04
- Stochastic Oscillator
- AMIX 24.35
- CELZ 40.00
About AMIX AUTONOMIX MEDICAL INC
Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.